Best of the Week
Most Popular
1. Dollargeddon - Gold Price to Soar Above $6,000 - P_Radomski_CFA
2.Is Gold Price On Verge Of A Bottom, See For Yourself - Chris_Vermeulen
3.Dow Stock Market Trend Forecast 2018 - Nadeem_Walayat
4.Gold Price to Plunge Below $1000 - Key Factors for Gold & Silver Investors - P_Radomski_CFA
5.Why The Uranium Price Must Go Up - Richard_Mills
6.Dow Stock Market Trend Forecast 2018 - Video - Nadeem_Walayat
7.Jim Rogers on Gold, Silver, Bitcoin and Blockchain’s “Spectacular Future” - GoldCore
8.More Signs That the Stock Market Will Rally Until 2019 - Troy_Bombardia
9.It's Time for A New Economic Strategy in Turkey - Steve_H_Hanke
10.Fiat Currency Inflation, And Collapse Insurance - Raymond_Matison
Last 7 days
Golden Sunsets in the Land of U.S. Dollar Hegemony - 20th Sep 18
5 Things to Keep in Mind When Buying a Luxury Car in Dubai - 20th Sep 18
Gold Price Seasonal Trend Analysis - Video - 20th Sep 18
The Stealth Reason Why the Stock Market Keeps On Rising - 20th Sep 18
Sheffield School Applications Crisis Eased by New Secondary Schools Places - 20th Sep 18
Precious Metals Sector: It’s 2013 All Over Again - 19th Sep 18
US Dollar Head & Shoulders Triggered. What's Next? - 19th Sep 18
Prepare for the Stock Market’s Volatility to Increase - 19th Sep 18
The Beginning of the End of the Dollar - 19th Sep 18
Land Rover Discovery Sport 'Approved Used' Bad Paint Job - Inchcape Chester - 19th Sep 18
Are Technology and FANG Stocks Bottoming? - 18th Sep 18
Predictive Trading Model Suggests Falling Stock Prices During US Elections - 18th Sep 18
Lehman Brothers Financial Collapse - Ten Years Later - 18th Sep 18
Financial Crisis Markets Reality Check Now in Progress - 18th Sep 18
Gold’s Ultimate Confirmation - 18th Sep 18
Omanization: a 20-year Process to Fight Volatile Oil Prices  - 18th Sep 18
Sheffield Best Secondary Schools Rankings and Trend Trajectory for Applications 2018 - 18th Sep 18
Gold / US Dollar Inverse Correlation - 17th Sep 18
The Apple Story - Trump Tariffs Penalize US Multinationals - 17th Sep 18
Wall Street Created Financial Crash Catastrophe Ten Years Later - 17th Sep 18
Trade Wars Are Going To Crash This Stock Market - 17th Sep 18
Why Is Apple Giving This Tiny Stock A $900 Million Opportunity? - 17th Sep 18
Financial Markets Macro/Micro View: Waves and Cycles - 17th Sep 18
Stock Market Bulls Prevail – for Now! - 17th Sep 18
GBPUSD Set to Explode Higher - 17th Sep 18
The China Threat - Global Crisis Hot Spots & Pressure Points - 17th Sep 18 - Jim_Willie_CB
Silver's Relationship with Gold Reaching Historical Extremes - 16th Sep 18
Emerging Markets to Follow and Those to Avoid - 16th Sep 18
Investing - Look at the Facts to Find the Truth - 16th Sep 18
Gold Stocks Forced Capitulation - 15th Sep 18
Hindenburg Omen & Consumer Confidence: More Signs of Stock Market Trouble in 2019 - 15th Sep 18
Trading The Global Future - Bad Consequences - 15th Sep 18
Central Banks Have Gone Rogue, Putting Us All at Risk - 15th Sep 18
Gold Price Seasonal Trend Analysis - 14th Sep 18
Growing Number of Small Businesses Opening – and Closing – In the UK - 14th Sep 18
Gold Price Trend Analysis - Video - 14th Sep 18
Esports Is Exploding—Here’s 3 Best Stocks to Profit From - 13th Sep 18
The Four Steel Men Behind Trump’s Trade War - 13th Sep 18
How Trump Tariffs Could Double America’s Trade Losses - 13th Sep 18
Next Financial Crisis Is Already Here! John Lewis 99% Profits CRASH - Retail Sector Collapse - 13th Sep 18
Trading Cryptocurrencies: To Win, You Must Know Where You're Wrong - 13th Sep 18
Gold, Silver, and USD Index - Three Important “Nothings” - 13th Sep 18
Precious Metals Sector On a Long-term SELL Signal - 13th Sep 18
Does Gambling Regulation Work - A Case Study - 13th Sep 18
The Ritual Burial of the US Constitution - 12th Sep 18
Stock Market Final Probe Higher ... Then the PANIC! - 12th Sep 18
Gold Nuggets And Silver Bullets - 12th Sep 18
Bitcoin Trading - SEC Strikes Again - 12th Sep 18

Market Oracle FREE Newsletter

Trading Any Market

How to Ride the Biotech Boom

Companies / BioTech Jul 10, 2013 - 04:24 PM GMT

By: Investment_U

Companies

Marc Lichtenfeld writes: hope you had a great Fourth of July. I had a blast hanging out with family and friends. However, we had a long drive home so we missed the fireworks.

That’s OK, though. I’ve seen plenty of fireworks in the past two weeks in the biotech sector.

Since June 24, the Amex Biotech Index (NYSE: BTK) is up over 11%. That’s a solid year for most indexes. Year to date, the group is up over 34%.


Typically, biotech stocks, particularly those that deal with cancer, run up in the spring, ahead of the annual meeting of the American Society of Clinical Oncology (ASCO). At this meeting, nearly every major (and minor) player in the fight against cancer presents data from various clinical and preclinical trials.

After the ASCO meeting, which takes place the first week of June, biotech stocks usually take a breather, sometimes for the rest of the year until they start moving in anticipation of the J.P. Morgan Healthcare Conference – the first big one of the year – in early January.

Acquisition Fever Fuels Run-up
This year, biotech hit a high in mid-May and then backed off. But in late June the sector ignited. Fueling the fire was the proposed acquisition of Onyx Pharmaceuticals (Nasdaq: ONXX) by Amgen (Nasdaq: AMGN) for a 38% premium.

Onyx’s management rejected the proposal and put itself up for sale. The stock opened 53% higher and has climbed a few points since.

Other cancer stocks have also soared. ImmunoGen (Nasdaq: IMGN) is up 20% in the past few weeks. And Celldex Therapeutics (Nasdaq: CLDX), which has drugs in development for brain cancer and breast cancer, has spiked 63% in just two weeks.

Fortunately, these stocks are in my Healthcare Profits Alert service, so my subscribers have been enjoying the ride higher. But there have been plenty of other biotech stocks that are not in the portfolio that have been moving up as well: Alnylam (Nasdaq: ALNY), and Immunomedics (Nasdaq: IMMU) to name just a few.

Can the run-up continue? I believe it can.

Right now there is a lot of excitement over a possible acquisition of Onyx. If the company does in fact get bought at a decent premium, that’s going to make takeover speculation go into overdrive.

Plus, big pharmaceutical companies desperately need new drugs. And biotech can provide them. Smaller companies like Celldex Therapeutics can be bought at a much lower price than a larger company like Onyx. There are many small-cap biotechs with promising drugs that would not be an expensive purchase for a large pharma company like Merck (NYSE: MRK) or Bristol-Myers Squibb (NYSE: BMY).

Additionally, the technicals look strong:

The index recently broke out of a flag pattern. A flag is a short-term move that goes against the prevailing trend. You can see that the biotech index has been moving up since November, but in May and June the index took a break from its ascent. Now it has broken out above that flag pattern.

Flags are fairly reliable technical patterns. This one suggests that the index can still go meaningfully higher. I wouldn’t be surprised to see it hit 2,300 before the move is over.

How to Play It
If you agree, there are several ways to play this move. You can buy a biotech ETF like iShares Nasdaq Biotechnology (Nasdaq: IBB); you can find some biotech stocks with promising drugs that have shown efficacy and (very important) a strong safety profile in clinical trials; or you can rely on someone to help guide you, like the readers of my Healthcare Profits Alert do.

Whichever way you go, consider putting some of your speculative money to work in this sector, as there should be more spectacular gains on the way.

Editor’s Note: We need to tip our collective hats to Marc. As he mentions above, he is treating his followers to phenomenal profits. A perfect example comes from an alert he mailed his Healthcare Profits Alert subscribers yesterday. In it, Marc details the action to take on four profitable positions. One has tripled in price. Another is up by 229%. The third play is up 67%. And the fourth is up by 7%… in less than a month. Clearly, market volatility won’t shake Marc’s winning system. And that deserves a tip of our hat. To be one of the first to hear about his next winning recommendation, follow this link.

Source: http://www.investmentu.com/2013/July/ride-the-biotech-boom.html

http://www.investmentu.com

Copyright © 1999 - 2013 by The Oxford Club, L.L.C All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Investment U, Attn: Member Services , 105 West Monument Street, Baltimore, MD 21201 Email: CustomerService@InvestmentU.com

Disclaimer: Investment U Disclaimer: Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Investment U Archive

© 2005-2018 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules